MEDINDIA
English
हिन्दी
Español
français
中文
Email
4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Loxapine is combined with Gamma Hydroxybutyric Acid.
Acepromazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Aceprometazine.
Aclidinium
The therapeutic efficacy of Aclidinium can be decreased when used in combination with Loxapine.
Albuterol
The therapeutic efficacy of Salbutamol can be decreased when used in combination with Loxapine.
Alfaxalone
The risk or severity of adverse effects can be increased when Loxapine is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Loxapine is combined with Alfentanil.
Almotriptan
The risk or severity of adverse effects can be increased when Almotriptan is combined with Loxapine.
Alphaprodine
The risk or severity of adverse effects can be increased when Loxapine is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Loxapine.
Amantadine
The therapeutic efficacy of Loxapine can be decreased when used in combination with Amantadine.
Amisulpride
Loxapine may increase the antipsychotic activities of Amisulpride.
Amitriptyline
The risk or severity of adverse effects can be increased when Loxapine is combined with Amitriptyline.
Amobarbital
The risk or severity of adverse effects can be increased when Loxapine is combined with Amobarbital.
Amoxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Amoxapine.
Amphetamine
Loxapine may decrease the stimulatory activities of Amphetamine.
Apomorphine
The therapeutic efficacy of Loxapine can be decreased when used in combination with Apomorphine.
Arformoterol
The therapeutic efficacy of Arformoterol can be decreased when used in combination with Loxapine.
Aripiprazole
The risk or severity of adverse effects can be increased when Loxapine is combined with Aripiprazole.
Articaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Articaine.
Asenapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Asenapine.
Azelastine
Loxapine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Baclofen
The risk or severity of adverse effects can be increased when Loxapine is combined with Baclofen.
Bambuterol
The therapeutic efficacy of Bambuterol can be decreased when used in combination with Loxapine.
Barbital
The risk or severity of adverse effects can be increased when Loxapine is combined with Barbital.
Beclomethasone Dipropionate
The therapeutic efficacy of Beclomethasone dipropionate can be decreased when used in combination with Loxapine.
Benoxinate
The risk or severity of adverse effects can be increased when Loxapine is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Loxapine is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Benzocaine.
Benzphetamine
Loxapine may decrease the stimulatory activities of Benzphetamine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Loxapine is combined with Benzyl alcohol.
Brexpiprazole
The risk or severity of adverse effects can be increased when Loxapine is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Loxapine.
Bromazepam
The risk or severity of adverse effects can be increased when Loxapine is combined with Bromazepam.
Bromocriptine
The therapeutic efficacy of Loxapine can be decreased when used in combination with Bromocriptine.
Bromperidol
The risk or severity of adverse effects can be increased when Loxapine is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Loxapine is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Loxapine is combined with Brotizolam.
Budesonide
The therapeutic efficacy of Budesonide can be decreased when used in combination with Loxapine.
Bupivacaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Bupivacaine.
Buprenorphine
Loxapine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Buspirone
The risk or severity of adverse effects can be increased when Loxapine is combined with Buspirone.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Loxapine.
Butalbital
The risk or severity of adverse effects can be increased when Loxapine is combined with Butalbital.
Butamben
The risk or severity of adverse effects can be increased when Loxapine is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Loxapine is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Loxapine is combined with Butorphanol.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Loxapine.
Carbamazepine
The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Loxapine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Loxapine is combined with Carbinoxamine.
Carisoprodol
The risk or severity of adverse effects can be increased when Loxapine is combined with Carisoprodol.
Cetirizine
The risk or severity of adverse effects can be increased when Loxapine is combined with Cetirizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Loxapine is combined with Chloral hydrate.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Loxapine is combined with Chlordiazepoxide.
Chlormethiazole
The risk or severity of adverse effects can be increased when Loxapine is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Loxapine is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Chloroprocaine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Loxapine is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Loxapine is combined with Chlorphenamine.
Chlorpromazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Loxapine is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Loxapine is combined with Chlorzoxazone.
Ciclesonide
The therapeutic efficacy of Ciclesonide can be decreased when used in combination with Loxapine.
Citalopram
The risk or severity of adverse effects can be increased when Loxapine is combined with Citalopram.
Clemastine
The risk or severity of adverse effects can be increased when Loxapine is combined with Clemastine.
Clidinium
The risk or severity of adverse effects can be increased when Loxapine is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Loxapine is combined with Clidinium.
Clobazam
The risk or severity of adverse effects can be increased when Loxapine is combined with Clobazam.
Clomipramine
The risk or severity of adverse effects can be increased when Loxapine is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Loxapine is combined with Clonazepam.
Clonidine
The risk or severity of adverse effects can be increased when Loxapine is combined with Clonidine.
Clorazepate
The risk or severity of adverse effects can be increased when Loxapine is combined with Clorazepate.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Loxapine is combined with Clorazepate.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Loxapine.
Cocaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Loxapine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Loxapine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Loxapine.
Cyclizine
The risk or severity of adverse effects can be increased when Loxapine is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Loxapine is combined with Cyclobenzaprine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Loxapine is combined with Cyproheptadine.
Dantrolene
The risk or severity of adverse effects can be increased when Loxapine is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Loxapine is combined with Dapiprazole.
Desflurane
The risk or severity of adverse effects can be increased when Loxapine is combined with Desflurane.
Desipramine
The risk or severity of adverse effects can be increased when Loxapine is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Loxapine is combined with Desloratadine.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Loxapine is combined with Desvenlafaxine.
Deutetrabenazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Deutetrabenazine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Loxapine is combined with Dexbrompheniramine.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Loxapine is combined with Dexmedetomidine.
Dextroamphetamine
Loxapine may decrease the stimulatory activities of Dextroamphetamine.
Dextromethorphan
The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Loxapine.
Dextromoramide
The risk or severity of adverse effects can be increased when Loxapine is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Loxapine is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Loxapine is combined with Diazepam.
Dibucaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Cinchocaine.
Diethylpropion
Loxapine may decrease the stimulatory activities of Diethylpropion.
Difenoxin
The risk or severity of adverse effects can be increased when Loxapine is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Loxapine is combined with Dihydrocodeine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Loxapine.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Loxapine is combined with Dimenhydrinate.
Diphenhydramine
The risk or severity of adverse effects can be increased when Loxapine is combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Loxapine is combined with Diphenoxylate.
Doxepin
The risk or severity of adverse effects can be increased when Loxapine is combined with Doxepin.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Loxapine.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Loxapine.
Duloxetine
The risk or severity of adverse effects can be increased when Loxapine is combined with Duloxetine.
Dyclonine
The risk or severity of adverse effects can be increased when Loxapine is combined with Dyclonine.
Efavirenz
The risk or severity of adverse effects can be increased when Loxapine is combined with Efavirenz.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Loxapine.
Enflurane
The risk or severity of adverse effects can be increased when Loxapine is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Loxapine is combined with Entacapone.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Loxapine.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Loxapine.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Loxapine.
Escitalopram
The risk or severity of adverse effects can be increased when Loxapine is combined with Escitalopram.
Estazolam
The risk or severity of adverse effects can be increased when Loxapine is combined with Estazolam.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Loxapine.
Ethanol
Loxapine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Loxapine is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Loxapine is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Loxapine is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Loxapine is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Loxapine is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Loxapine is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Loxapine is combined with Etifoxine.
Etomidate
The risk or severity of adverse effects can be increased when Loxapine is combined with Etomidate.
Ezogabine
The risk or severity of adverse effects can be increased when Loxapine is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Loxapine is combined with Felbamate.
Fenoterol
The therapeutic efficacy of Fenoterol can be decreased when used in combination with Loxapine.
Fentanyl
The risk or severity of adverse effects can be increased when Loxapine is combined with Fentanyl.
Fexofenadine
The risk or severity of adverse effects can be increased when Loxapine is combined with Fexofenadine.
Flibanserin
The risk or severity of adverse effects can be increased when Loxapine is combined with Flibanserin.
Flunarizine
The risk or severity of adverse effects can be increased when Loxapine is combined with Flunarizine.
Flunisolide
The therapeutic efficacy of Flunisolide can be decreased when used in combination with Loxapine.
Flunisolide Anhydrous (obsolete)
The therapeutic efficacy of Flunisolide can be decreased when used in combination with Loxapine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Loxapine is combined with Flunitrazepam.
Fluoxetine
The risk or severity of adverse effects can be increased when Loxapine is combined with Fluoxetine.
Flupenthixol
The risk or severity of adverse effects can be increased when Loxapine is combined with Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Fluphenazine.
Flurazepam
The risk or severity of adverse effects can be increased when Loxapine is combined with Flurazepam.
Fluspirilene
The risk or severity of adverse effects can be increased when Loxapine is combined with Fluspirilene.
Fluticasone Furoate
The therapeutic efficacy of Fluticasone furoate can be decreased when used in combination with Loxapine.
Fluticasone propionate
The therapeutic efficacy of Fluticasone propionate can be decreased when used in combination with Loxapine.
Fluvoxamine
The risk or severity of adverse effects can be increased when Loxapine is combined with Fluvoxamine.
Formoterol
The therapeutic efficacy of Formoterol can be decreased when used in combination with Loxapine.
Fosphenytoin
The risk or severity of adverse effects can be increased when Loxapine is combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Loxapine is combined with Fospropofol.
Frovatriptan
The risk or severity of adverse effects can be increased when Frovatriptan is combined with Loxapine.
Gabapentin
The risk or severity of adverse effects can be increased when Loxapine is combined with Gabapentin.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Loxapine is combined with Gabapentin Enacarbil.
Glutethimide
The risk or severity of adverse effects can be increased when Loxapine is combined with Glutethimide.
Guanfacine
The risk or severity of adverse effects can be increased when Loxapine is combined with Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Loxapine is combined with Halazepam.
Haloperidol
The risk or severity of adverse effects can be increased when Loxapine is combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Loxapine is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Loxapine is combined with Heroin.
Hexobarbital
The risk or severity of adverse effects can be increased when Loxapine is combined with Hexobarbital.
Hydrocodone
Loxapine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Loxapine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Loxapine.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Loxapine.
Iloperidone
The risk or severity of adverse effects can be increased when Loxapine is combined with Iloperidone.
Imipramine
The risk or severity of adverse effects can be increased when Loxapine is combined with Imipramine.
Indacaterol
The therapeutic efficacy of Indacaterol can be decreased when used in combination with Loxapine.
Ipratropium
The therapeutic efficacy of Ipratropium bromide can be decreased when used in combination with Loxapine.
Ipratropium cation
The therapeutic efficacy of Ipratropium bromide can be decreased when used in combination with Loxapine.
Isocarboxazid
The therapeutic efficacy of Loxapine can be increased when used in combination with Isocarboxazid.
Isoflurane
The risk or severity of adverse effects can be increased when Loxapine is combined with Isoflurane.
Ketamine
The risk or severity of adverse effects can be increased when Loxapine is combined with Ketamine.
Ketazolam
The risk or severity of adverse effects can be increased when Loxapine is combined with Ketazolam.
Lamotrigine
The risk or severity of adverse effects can be increased when Loxapine is combined with Lamotrigine.
Levalbuterol
The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Loxapine.
Levetiracetam
The risk or severity of adverse effects can be increased when Loxapine is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Loxapine is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Loxapine is combined with Levocetirizine.
Levodopa
The therapeutic efficacy of Loxapine can be decreased when used in combination with Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Loxapine is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Loxapine is combined with Levomilnacipran.
Levorphanol
The risk or severity of adverse effects can be increased when Loxapine is combined with Levorphanol.
Lidocaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Lidocaine.
Linezolid
The risk or severity of adverse effects can be increased when Linezolid is combined with Loxapine.
Lisdexamfetamine
Loxapine may decrease the stimulatory activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Loxapine may decrease the stimulatory activities of Lisdexamfetamine.
Lithium
Lithium may increase the neurotoxic activities of Loxapine.
Lithium Cation
Lithium may increase the neurotoxic activities of Loxapine.
Lofexidine
The therapeutic efficacy of Loxapine can be increased when used in combination with Lofexidine.
Loratadine
The risk or severity of adverse effects can be increased when Loxapine is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Loxapine is combined with Lorazepam.
Lorcaserin
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Loxapine.
Lormetazepam
The risk or severity of adverse effects can be increased when Loxapine is combined with Lormetazepam.
Lurasidone
The risk or severity of adverse effects can be increased when Loxapine is combined with Lurasidone.
Magnesium Sulfate
The therapeutic efficacy of Loxapine can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Loxapine can be increased when used in combination with Magnesium sulfate.
Maprotiline
The risk or severity of adverse effects can be increased when Loxapine is combined with Maprotiline.
Meclizine
The risk or severity of adverse effects can be increased when Loxapine is combined with Meclizine.
Melatonin
The risk or severity of adverse effects can be increased when Loxapine is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Loxapine is combined with Pethidine.
Mephentermine
Loxapine may decrease the stimulatory activities of Mephentermine.
Mephobarbital
The risk or severity of adverse effects can be increased when Loxapine is combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Loxapine.
Mequitazine
Loxapine may increase the arrhythmogenic activities of Mequitazine.
Mesoridazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Mesoridazine.
Metaproterenol
The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Loxapine.
Metaxalone
The risk or severity of adverse effects can be increased when Loxapine is combined with Metaxalone.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Loxapine.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Loxapine is combined with Methadyl Acetate.
Methamphetamine
Loxapine may decrease the stimulatory activities of Methamphetamine.
Methapyrilene
The risk or severity of adverse effects can be increased when Loxapine is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Loxapine is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Loxapine is combined with Methocarbamol.
Methohexital
The risk or severity of adverse effects can be increased when Loxapine is combined with Methohexital.
Methotrimeprazine
Loxapine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Loxapine is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Loxapine is combined with Methsuximide.
Methylphenidate
The risk or severity of adverse effects can be increased when Loxapine is combined with Methylphenidate.
Metoclopramide
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Loxapine.
Metylperon
The risk or severity of adverse effects can be increased when Loxapine is combined with Melperone.
Metyrosine
Loxapine may increase the sedative activities of Metyrosine.
Midazolam
The risk or severity of adverse effects can be increased when Loxapine is combined with Midazolam.
Milnacipran
The risk or severity of adverse effects can be increased when Loxapine is combined with Milnacipran.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Loxapine.
Mirtazapine
Loxapine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Moclobemide
The risk or severity of adverse effects can be increased when Moclobemide is combined with Loxapine.
Molindone
The risk or severity of adverse effects can be increased when Loxapine is combined with Molindone.
Mometasone
The therapeutic efficacy of Mometasone can be decreased when used in combination with Loxapine.
Montelukast
The therapeutic efficacy of Montelukast can be decreased when used in combination with Loxapine.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Loxapine.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Loxapine.
Nalbuphine
The risk or severity of adverse effects can be increased when Loxapine is combined with Nalbuphine.
Naratriptan
The risk or severity of adverse effects can be increased when Naratriptan is combined with Loxapine.
Nefazodone
The risk or severity of adverse effects can be increased when Loxapine is combined with Nefazodone.
Nitrazepam
The risk or severity of adverse effects can be increased when Loxapine is combined with Nitrazepam.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Loxapine is combined with Nitrous oxide.
Nordazepam
The risk or severity of adverse effects can be increased when Loxapine is combined with Nordazepam.
Norflurane
The risk or severity of adverse effects can be increased when Loxapine is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Loxapine is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Loxapine is combined with Nortriptyline.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Loxapine.
Olodaterol
The therapeutic efficacy of Olodaterol can be decreased when used in combination with Loxapine.
Olopatadine
The risk or severity of adverse effects can be increased when Loxapine is combined with Olopatadine.
Omalizumab
The therapeutic efficacy of Omalizumab can be decreased when used in combination with Loxapine.
Ondansetron
The risk or severity of adverse effects can be increased when Loxapine is combined with Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Loxapine is combined with Opium.
Orphenadrine
Loxapine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Oxazepam
The risk or severity of adverse effects can be increased when Loxapine is combined with Oxazepam.
Oxprenolol
The risk or severity of adverse effects can be increased when Loxapine is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Loxapine is combined with Oxycodone.
Oxymorphone
The risk or severity of adverse effects can be increased when Loxapine is combined with Oxymorphone.
p-Hydroxyamphetamine
Loxapine may decrease the stimulatory activities of Hydroxyamphetamine.
Paliperidone
The risk or severity of adverse effects can be increased when Loxapine is combined with Paliperidone.
Paraldehyde
Loxapine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Loxapine.
Paroxetine
The risk or severity of adverse effects can be increased when Loxapine is combined with Paroxetine.
Pentazocine
The risk or severity of adverse effects can be increased when Loxapine is combined with Pentazocine.
Pentobarbital
The risk or severity of adverse effects can be increased when Pentobarbital is combined with Loxapine.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Loxapine.
Perazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Perazine.
Perphenazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Perphenazine.
Phenelzine
The risk or severity of adverse effects can be increased when Phenelzine is combined with Loxapine.
Phenobarbital
The risk or severity of adverse effects can be increased when Loxapine is combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Loxapine is combined with Phenoxyethanol.
Phentermine
Loxapine may decrease the stimulatory activities of Phentermine.
PHENTERMINE RESIN
Loxapine may decrease the stimulatory activities of Phentermine.
Phenytoin
The risk or severity of adverse effects can be increased when Loxapine is combined with Phenytoin.
Pimozide
The risk or severity of adverse effects can be increased when Loxapine is combined with Pimozide.
Pipamperone
The risk or severity of adverse effects can be increased when Loxapine is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Pipotiazine.
Pirbuterol
The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Loxapine.
Piribedil
The therapeutic efficacy of Loxapine can be decreased when used in combination with Piribedil.
Pirinitramide
The risk or severity of adverse effects can be increased when Loxapine is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Loxapine is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Loxapine is combined with Pomalidomide.
Pramipexole
Loxapine may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Loxapine is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Loxapine is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Loxapine can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Prilocaine.
Primidone
The risk or severity of adverse effects can be increased when Loxapine is combined with Primidone.
Procaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Procaine.
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Loxapine.
Prochlorperazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Prochlorperazine.
Promazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Promethazine.
Proparacaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Loxapine is combined with Propofol.
Propoxyphene
The risk or severity of adverse effects can be increased when Loxapine is combined with Dextropropoxyphene.
Protriptyline
The risk or severity of adverse effects can be increased when Loxapine is combined with Protriptyline.
Pseudoephedrine
Loxapine may decrease the stimulatory activities of Pseudoephedrine.
Quazepam
The risk or severity of adverse effects can be increased when Loxapine is combined with Quazepam.
Quetiapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Loxapine is combined with Quetiapine.
Quinagolide
The therapeutic efficacy of Quinagolide can be decreased when used in combination with Loxapine.
Ramelteon
The risk or severity of adverse effects can be increased when Loxapine is combined with Ramelteon.
Rasagiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Loxapine.
Remifentanil
The risk or severity of adverse effects can be increased when Loxapine is combined with Remifentanil.
Remoxipride
The risk or severity of adverse effects can be increased when Loxapine is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Loxapine.
Risperidone
The risk or severity of adverse effects can be increased when Loxapine is combined with Risperidone.
Rizatriptan
The risk or severity of adverse effects can be increased when Rizatriptan is combined with Loxapine.
Roflumilast
The therapeutic efficacy of Roflumilast can be decreased when used in combination with Loxapine.
Ropinirole
Loxapine may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Ropivacaine.
Rotigotine
Loxapine may increase the sedative activities of Rotigotine.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Loxapine.
Salmeterol
The therapeutic efficacy of Salmeterol can be decreased when used in combination with Loxapine.
Scopolamine
The risk or severity of adverse effects can be increased when Loxapine is combined with Scopolamine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Loxapine is combined with Scopolamine.
Secobarbital
The risk or severity of adverse effects can be increased when Loxapine is combined with Secobarbital.
Selegiline
The risk or severity of adverse effects can be increased when Selegiline is combined with Loxapine.
Sertindole
The risk or severity of adverse effects can be increased when Loxapine is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Loxapine is combined with Sertraline.
Sevoflurane
The risk or severity of adverse effects can be increased when Loxapine is combined with Sevoflurane.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Loxapine.
Sufentanil
The risk or severity of adverse effects can be increased when Loxapine is combined with Sufentanil.
Sulpiride
Loxapine may increase the antipsychotic activities of Sulpiride.
Sumatriptan
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Loxapine.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Sumatriptan is combined with Loxapine.
Suvorexant
Loxapine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Loxapine.
Tasimelteon
The risk or severity of adverse effects can be increased when Loxapine is combined with Tasimelteon.
Tedizolid
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Loxapine.
Tedizolid Phosphate
The risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Loxapine.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Loxapine.
Terbutaline
The therapeutic efficacy of Terbutaline can be decreased when used in combination with Loxapine.
Terbutaline Sulfate
The therapeutic efficacy of Terbutaline can be decreased when used in combination with Loxapine.
Tetrabenazine
The risk or severity of adverse effects can be increased when Tetrabenazine is combined with Loxapine.
Tetracaine
The risk or severity of adverse effects can be increased when Loxapine is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Loxapine is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Loxapine.
Thalidomide
Loxapine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Thiamylal
The risk or severity of adverse effects can be increased when Loxapine is combined with Thiamylal.
Thiopental
The risk or severity of adverse effects can be increased when Loxapine is combined with Thiopental.
Thiopental Sodium
The risk or severity of adverse effects can be increased when Loxapine is combined with Thiopental.
Thioridazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Thioridazine.
Thiothixene
The risk or severity of adverse effects can be increased when Loxapine is combined with Thiothixene.
Tiagabine
The risk or severity of adverse effects can be increased when Loxapine is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Loxapine is combined with Tiapride.
Tiotropium
The therapeutic efficacy of Tiotropium can be decreased when used in combination with Loxapine.
Tizanidine
The risk or severity of adverse effects can be increased when Loxapine is combined with Tizanidine.
Tolcapone
The risk or severity of adverse effects can be increased when Loxapine is combined with Tolcapone.
Topiramate
The risk or severity of adverse effects can be increased when Loxapine is combined with Topiramate.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Loxapine.
Tranylcypromine
The risk or severity of adverse effects can be increased when Loxapine is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Loxapine is combined with Trazodone.
Triamcinolone
The therapeutic efficacy of Triamcinolone can be decreased when used in combination with Loxapine.
Triazolam
The risk or severity of adverse effects can be increased when Loxapine is combined with Triazolam.
Triazulenone
The risk or severity of adverse effects can be increased when Loxapine is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Trifluoperazine.
Triflupromazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Triflupromazine.
Trimipramine
The risk or severity of adverse effects can be increased when Loxapine is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Loxapine is combined with Triprolidine.
Tulobuterol
The therapeutic efficacy of Tulobuterol can be decreased when used in combination with Loxapine.
Umeclidinium
The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Loxapine.
Urethane
The risk or severity of adverse effects can be increased when Loxapine is combined with Ethyl carbamate.
Valproate
The risk or severity of adverse effects can be increased when Loxapine is combined with Valproic Acid.
Valproic Acid
The risk or severity of adverse effects can be increased when Loxapine is combined with Valproic Acid.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Loxapine.
Venlafaxine
The risk or severity of adverse effects can be increased when Loxapine is combined with Venlafaxine.
Vigabatrin
The risk or severity of adverse effects can be increased when Loxapine is combined with Vigabatrin.
Vilanterol
The therapeutic efficacy of Vilanterol can be decreased when used in combination with Loxapine.
Vilazodone
The risk or severity of adverse effects can be increased when Vilazodone is combined with Loxapine.
Vortioxetine
The risk or severity of adverse effects can be increased when Loxapine is combined with Vortioxetine.
Xylazine
The risk or severity of adverse effects can be increased when Loxapine is combined with Xylazine.
Zafirlukast
The therapeutic efficacy of Zafirlukast can be decreased when used in combination with Loxapine.
Zaleplon
The risk or severity of adverse effects can be increased when Loxapine is combined with Zaleplon.
Ziconotide
The risk or severity of adverse effects can be increased when Loxapine is combined with Ziconotide.
Zileuton
The therapeutic efficacy of Zileuton can be decreased when used in combination with Loxapine.
Ziprasidone
The risk or severity of adverse effects can be increased when Ziprasidone is combined with Loxapine.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Loxapine.
Zolpidem
Loxapine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Loxapine is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Loxapine is combined with Zopiclone.
Zotepine
The risk or severity of adverse effects can be increased when Loxapine is combined with Zotepine.
Zuclopenthixol
The risk or severity of adverse effects can be increased when Loxapine is combined with Zuclopenthixol.
